STOCK TITAN
  1. Home
  2. Sec-filings
  3. NTRA
  4. [Form 4] Natera, Inc. Insider Trading Activity

NTRA insider sale: 4,000 shares via 10b5-1 at ~$200

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Natera, Inc. (NTRA) — Form 4 insider transaction

A reporting person who is a director and co‑founder disclosed open‑market sales of Natera common stock on 11/03/2025 under a Rule 10b5‑1 trading plan adopted on June 7, 2024. Two separate sales of 2,000 shares each were executed through trusts, for a total of 4,000 shares. One sale had a weighted average price of $200.1368 with trade prices ranging from $200.00 to $200.30; the other was reported at $200.00 per share.

Following the transactions, the filing lists 235,730 shares beneficially owned directly. The trusts are held for the benefit of their beneficiaries, and the reporting person disclaims beneficial ownership of those securities.

Positive

  • None.

Negative

  • None.

Insights

Routine insider sales disclosed under a pre-set 10b5-1 plan.

The filing reports two trust-related sales totaling 4,000 Natera shares on 11/03/2025. One block was sold at a weighted average of $200.1368 within a $200.00–$200.30 range; the other at $200.00. The sales were effected pursuant to a Rule 10b5‑1 plan adopted on June 7, 2024.

Post-transaction, the filing shows 235,730 shares beneficially owned directly. Trust-held shares are for beneficiaries, with beneficial ownership disclaimed. Insider activity of this type is commonly administrative; actual impact depends on future disclosures and market context.

Insider Sheena Jonathan
Role Director
Sold 4,000 shs ($800K)
Type Security Shares Price Value
Sale Common Stock 2,000 $200.1368 $400K
Sale Common Stock 2,000 $200.00 $400K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 26,032 shares (Indirect, By Caraluna 1 Trust); Common Stock — 235,730 shares (Direct)
Footnotes (1)
  1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sheena Jonathan
(Last) (First) (Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
(Street)
AUSTIN TX 78753
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) X Other (specify below)
CO-FOUNDER
3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/03/2025 S 2,000(1) D $200.1368(2) 26,032 I By Caraluna 1 Trust(3)
Common Stock 11/03/2025 S 2,000(1) D $200 26,032 I By Caraluna 2 Trust(3)
Common Stock 235,730 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
/s/ Vincent Fontanilla, Attorney-in-Fact 11/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

How many Natera (NTRA) shares were sold in this Form 4?

Two sales of 2,000 shares each were disclosed, totaling 4,000 shares.

What prices were reported for the NTRA insider sales?

One sale had a weighted average of $200.1368 with trades from $200.00 to $200.30; the other was at $200.00 per share.

When did the NTRA transactions occur?

The transactions took place on 11/03/2025.

Was a Rule 10b5-1 trading plan used?

Yes. The sales were effected under a Rule 10b5‑1 trading plan adopted on June 7, 2024.

How many NTRA shares does the reporting person hold directly after the trades?

The filing lists 235,730 shares beneficially owned directly following the transactions.

What is the nature of the trust holdings mentioned?

The trusts hold shares for the benefit of their beneficiaries, and the reporting person disclaims beneficial ownership of those securities.